EnduraCell BioActive Broccili Sprout - 80 Vegtable Capsules

EnduraCell

$58.95
(No reviews yet) Write a Review
Adding to cart… The item has been added

EnduraCell  BioActive - 80 Vegtable Capsules

 

 

  • Stimulates cellular antioxidant defences within the body
  • Broccoli sprouts may activate key enzymes in liver detoxification
  • EnduraCell BioActive® offers all the benefits of EnduraCell® powder in an easy to take capsule.

 

Serving Type: Vegetable Cellulose Capsule (suitable for vegetarians)

Application

Adults: Take 1-3 capsules twice daily or as directed by your Health Care Practitioner

Each capsule contains: 

EnduraCell® 100% Whole Broccoli Sprout Powder

(Brassica oleracea var. italica sprout powder)

700mg

NOTE: Cell-Logic EnduraCell® is hydroganically grown in a carefully controlled environment to maximise bioactivity. Our hydrogranic growing process does not use any herbicides, pesticides or other harmful chemicals. EnduraCell BioActive® is GMO free.

 

Available in bottles of 80 Capsules

 

EnduraCell BioActive® is a 100% whole Broccoli Sprout concentrate yielding cell-protective compounds. When taken as suggested, the unique phytonutrients of the Broccoli Sprouts contained in this product may assist in the maintenance and improvement of general well-being.

 

  • Stimulates cellular antioxidant defences within the body
  • Broccoli sprouts may activate key enzymes in liver detoxification

Broccoli sprouts when produced according to Cell-Logic’s proprietary Australian technology are a highly-concentrated source of Broccoli phytonutrients. The benefits of Broccoli in the human diet are well-known.

Cell-Logic’s unique EnduraCell® raw material is a 100% whole Broccoli Sprout concentrate with nothing removed and nothing added. EnduraCell BioActive offers all the benefits of EnduraCell® in an easy to consume capsule.

EnduraCell BioActive® does not contain goitrogens or significant levels of Vitamin K.

Warnings

Store below 30°C in a dry place away from direct light and moisture.

Very occasionally, gastro-intestinal adverse effects have been reported, and include nausea, gastro-abdominal discomfort and diarrhoea. Limited data available seem to indicate that such effects are limited to certain pre-existing gastro-intestinal conditions, in particular, those with dysbiosis. However, it has been observed that for those affected, the dose can be managed in a manner whereby the symptoms disappear and may not recur even after the consumption of larger doses.